Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη ανίχνευσης με ανοσοϊστοχημεία ελαττωματικού συστήματος επιδιόρθωσης (dMMR) σε ασθενείς με καρκίνο ενδομητρίου και συσχέτιση με ιστοπαθολογικά χαρακτηριστικά και παραμέτρους επιβίωσης

Abstract

dc:description

The aim of this study was to investigate the detection of mismatch repair system deficiency (dMMR) using immunohistochemistry in patients with endometrial cancer and its correlation with histopathological characteristics and survival parameters. For this purpose, a prospective cohort study was conducted during the period 12/2022–12/2025 at the Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki. The patient cohort consisted of women with diagnosed endometrial cancer who were treated at our clinic, and parameters were evaluated regarding tumor histological type and grade, myometrial invasion, presence of lymphovascular invasion, lymph node infiltration, final disease stage, and final risk group. The expression of DNA mismatch repair proteins (MLH1, PMS2, MSH2, and MSH6) was determined by immunohistochemistry on the surgical specimen of the uterus to assess the presence or absence of dMMR. Ninety-three women met the study inclusion criteria. The median age of patients was 66 years (range: 35–86 years). The most frequent stage was FIGO IA2 (29/93, 31.1%), followed by stages IB (15/93, 16.1%) and IIC (14/93, 15.05%). The endometrioid histological type predominated (80/93, 86.0%), while high-grade malignancy (grade 3) was observed in 27/93 (29.0%) cases. Deep myometrial invasion was identified in 42/93 (45.2%) patients, and lymphovascular invasion (LVSI) in 22/93 (23.7%). The dMMR status was significantly correlated with histological type (p = 0.027). Most non-endometrioid tumors retained an intact mismatch repair system (MMRp) (11/13, 84.6%), whereas dMMR was more frequent among endometrioid tumors (37/80, 46.2%). In contrast, no significant correlation was observed between dMMR and grade (p = 0.939). Furthermore, a statistically significant correlation was found between dMMR and deep myometrial invasion (p = 0.011), with deep invasion being more frequent in dMMR tumors (26/39, 66.6%) compared to MMRp tumors (16/54, 29.6%). Conversely, no significant associations were observed between dMMR and LVSI (p = 0.453), stage (p = 0.987), or lymph node infiltration (p = 1.000). In the multivariate logistic regression analysis, which included all histopathological variables and FIGO stage, with stage I as the reference category, two variables remained independently associated with dMMR status, namely deep myometrial invasion (OR = 4.30, 95% CI 1.63–11.37, p = 0.003) and histological type (OR = 0.04, 95% CI 0.002–0.97, p = 0.048), indicating that deeper myometrial invasion increased the odds of dMMR, while non-endometrioid histology significantly decreased the likelihood of dMMR. The median follow-up duration was 30 months (range: 3–36 months), during which 6/93 patients (6.4%) died (four in the dMMR group and two in the MMRp group) and 2/93 patients (2.2%) experienced disease recurrence (one in each group). Kaplan–Meier survival analysis did not demonstrate a statistically significant difference in Overall Survival (OS) between patients with dMMR and MMRp (log-rank test, p = 0.262). Similarly, the curves for Disease-Free Survival (DFS) did not differ significantly according to MMR status (log-rank test, p = 0.837). Furthermore, univariable Cox regression analysis did not demonstrate a significant association between dMMR status and OS (HR = 2.57, 95% CI 0.47–14.06, p = 0.275, six deaths among 93 patients) or DFS (HR = 1.33, 95% CI 0.08–21.34, p = 0.838, two recurrences among 93 patients), although a non-statistically significant trend toward increased mortality risk was observed in patients with dMMR. These findings demonstrate that the presence of dMMR is independently associated with deep myometrial invasion and endometrioid histological type. Despite the indicative trend toward increased mortality in dMMR patients, statistical significance was not achieved, attributable to the relatively small number of clinical events. Although the results suggest that systematic evaluation of the MMR system may improve risk stratification and guide a more personalized treatment approach, further studies with larger sample size and longer follow-up duration are needed to further clarify its prognostic significance.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Almperi, Emmanouela-Aliki
  • Αλμπέρη, Εμμανουέλα-Αλίκη

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62829

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Almperi, Emmanouela-Aliki; Αλμπέρη, Εμμανουέλα-Αλίκη. Μελέτη ανίχνευσης με ανοσοϊστοχημεία ελαττωματικού συστήματος επιδιόρθωσης (dMMR) σε ασθενείς με καρκίνο ενδομητρίου και συσχέτιση με ιστοπαθολογικά χαρακτηριστικά και παραμέτρους επιβίωσης. Aristotle University Of Thessaloniki (AUTH), 2026. http://hdl.handle.net/10442/hedi/62829